UK and Ireland bookmaker William Hill plc has announced the filing of a legal complaint against the proposed acquisition of NYX Gaming by fellow gaming heavyweight Scientific Games.
William Hill, a minority shareholder in NYX gaming, has requested that its convertible preference shares be converted into ordinary shares of NYX no later than December 4, 2017, to enable William Hill to vote in connection with the proposed acquisition. Any conversion would give William Hill 32% voting stock in NYX Gaming, allowing it to do so.
This move has been made by the firm “in order to protect the rights and interests of William Hill”; however numerous reports have suggested that the company is seeking to block the acquisition over concerns about the future potential revenue opportunities afforded by legalisation of sports betting in the US.
NYX subsidiary OpenBet would be ideally placed to take advantage of any relaxation in US sports betting legislation if the Supreme Court review, coincidentally due to take place on December 4, were to call for the repeal of the Professional and Amateur Sports Participation Act.
Full Content: CBS Detroit
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas